跳至主要内容
临床试验/JPRN-UMIN000005079
JPRN-UMIN000005079
已完成
未知

A randomized double blind, placebo-controlled trial of efficacy and safety of Kamishoyosan in patients with climacteric symptoms - A randomized double blind, placebo-controlled trial of efficacy and safety of Kamishoyosan in patients with climacteric symptoms

Hirosaki University Graduate School of Medicine0 个研究点目标入组 200 人2011年3月1日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Climacteric symptoms
发起方
Hirosaki University Graduate School of Medicine
入组人数
200
状态
已完成
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2011年3月1日
结束日期
2013年2月25日
最后更新
2年前
研究类型
Interventional
性别
Female

研究者

发起方
Hirosaki University Graduate School of Medicine

入排标准

入选标准

  • 未提供

排除标准

  • 1\) Patients with serious gastrointestinal weakness 2\) Patients with anorexia, nausea and/or vomiting 3\) Patients with psycho\-neurologic disease (SDS\>\=60\) 4\) Patients with a history of drug allergy or hypersensitivity reaction to Kampo medicine 5\) Patients with serious complications (hepatic, renal, cardiac diseases or malignancy tumor) 6\) Patients who have been participated in other clinical trial within 4months before enrollment, or will participate in a clinical trial. 7\) Patients who are assessed to be inappropriate for study participation by the investigator.

结局指标

主要结局

未指定

相似试验